Researchers say findings suggest it may be possible to stop cancer growth using approaches such as restraining TE activity in ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

Unlike traditional microscopes that use light or lenses, DNA microscopy creates images by calculating interactions among ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without ...